- Disclosure
〔Summary〕Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2023(pdf:1MB)
- Disclosure
Notice Regarding the Status of Repurchase of Treasury Stocks(pdf:114KB)
- Disclosure
Corporate Governance Report(pdf:406KB)
- Disclosure
Notice Regarding the Status of Repurchase of Treasury Stocks(pdf:110KB)
- Disclosure
Notice Regarding Sustainability Linked Bonds Terms of Issuance(pdf:200KB)
- Info
Temporary Relocation Due to Reconstruction of Tokyo Head Office Building
- Disclosure
Notice Regarding the Issuance of Sustainability Linked Bonds(pdf:379KB)
- Disclosure
Notice Regarding Introduction of Performance-Linked Stock-Based Compensation Plan for Directors(pdf:252KB)
- Disclosure
FYE March 2022 Financial Briefing(pdf:2MB)
- Disclosure
Notice Regarding the Status of Repurchase of Treasury Stocks(pdf:110KB)
- IR
The 107th Annual Shareholders’ Meeting
- Disclosure
Notice Concerning Differences Between Consolidated and Non-Consolidated Financial Results for the Fiscal Year Ended March 31,2022 and the Respective Results for the Previous Fiscal Year(pdf:94KB)
- Disclosure
FYE March 2022 Financial Highlights(pdf:998KB)
- Disclosure
Consolidated Financial Statements for the Fiscal Year Ended March 31, 2022(pdf:1MB)
- Disclosure
Notice Regarding ISS’s Recommendation Against Proposal 3 at the 107th Annual Shareholders’ Meeting(pdf:185KB)
- Disclosure
Notice Concerning Determination of Non-Financial Goals in Medium-Term Management Plan ACE 2.0(pdf:476KB)
- Info
NAGASE & CO., LTD. and Nagase ChemteX Corporation have received the ” The Society for Actinomycetes Japan Award for Corporation”
- News
Announcement of the Event The WPA Approved NAGASE Cup Para Athletics Competition(pdf:344KB)
- Info
NAGASE ranks 4th on the “Top 100 Chemical Distributors” list published by ICIS
- Disclosure
〔Summary〕Consolidated Financial Statements for the Fiscal Year Ended March 31,2022(pdf:372KB)